Biogen
Last update: November 27, 2020
Biotechnology
United States (USA)
Its 83 main executivesIts 9 subsidiaries
Recent executive movements at Biogen
Michael McDonnell will join the company as Executive Vice President and Chief Financial Officer on Aug. 15, 2020 (news posted on July 22 2020).
Jeffrey Capello, Executive Vice President and Chief Financial Officer, will leave the company on Aug. 15, 2020 (news posted on July 22 2020).
Create an alert
to follow the executive moves at Biogen.
Biogen is one of the...
Most searched biographies at Biogen
- Michel Vounatsos, Chief Executive Officer & Director
- Stelios Papadopoulos, Chairman of the Board
- Eric Rowinsky, Director
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Obalon Therapeutics and ReShape Lifesciences have merged (posted on Jan 22, 2021).
Integra Lifesciences has acquired ACell (posted on Jan 21, 2021).
Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
Other contacts in the Biotechnology industry
Latest news about Biogen
Biogen to Report Third Quarter 2020 Financial Results October 21, 2020 | Biogen
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab) | Biogen
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab) | Biogen
Reactive Statement to ICER’s announced plans to conduct an assessment on the value of aducanumab | Biogen
Reactive Statement to ICER’s announced plans to conduct an assessment on the value of aducanumab | Biogen
Biogen on Wikipedia, Google News & Yahoo Finance
Biogen on LinkedIn, Twitter & YouTube
Biogen has 9 subsidiaries including Biogen ANZ, Biogen BeLux and Biogen Canada. Biogen has 1,542 competitors including Agilyx (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France).
Contact by email its executives including Stelios Papadopoulos 
